Immunoassays employing non-particulate chemiluminescent reagent

Patent metadata

Field	Value
Publication number	US-9347947-B2
Application number	US-40329909-A
Country	US
Kind code	B2
Filing date	Mar 12, 2009
Priority date	Mar 12, 2009
Publication date	May 24, 2016
Grant date	May 24, 2016

Abstract

Methods and reagents are disclosed for conducting assays. Embodiments of the present methods and reagents are concerned with chemiluminescent reagents for determining the presence and/or amount of an analyte in a sample suspected of containing the analyte. The reagent is non-particulate and comprises a binding partner for the analyte and a chemiluminescent composition comprising an olefinic compound and a metal chelate. In embodiments of an assay, a combination is provided that comprises a sample suspected of containing the analyte, a chemiluminescent reagent as described above and a sensitizer reagent capable of generating singlet oxygen. The combination is subjected to conditions for binding of the analyte to the binding partner for the analyte. The sensitizer is activated and the amount of luminescence generated by the chemiluminescent composition is detected wherein the amount of luminescence is related to the amount of the analyte in the sample.

First claim

What is claimed is:

1. A method for determining the presence and/or amount of an analyte in a sample suspected of containing the analyte, the method comprising:
(a) providing in combination in an aqueous medium:
(i) the sample,
(ii) a chemiluminescent reagent, the reagent being non-particulate and soluble in the aqueous medium and comprising a binding partner for the analyte linked to a chemiluminescent composition comprising a metal chelate and an olefinic compound, and
(iii) a sensitizer reagent capable of generating singlet oxygen,

(b) subjecting the combination to conditions for binding of the analyte to the binding partner for the analyte, and
(c) activating the sensitizer and detecting the amount of luminescence generated by the chemiluminescent composition, the amount of luminescence being related to the amount of the analyte in the sample.

2. The method according to claim 1 wherein the binding partner for the analyte is covalently bound to the chemiluminescent composition by a linking group and wherein the linking group comprises a hydrophilic macromolecule.

3. The method according to claim 1 wherein the binding partner for the analyte is non-covalently bound to the chemiluminescent composition by a specific binding pair wherein one member of the specific binding pair is linked to the binding partner for the analyte and the other member of the specific binding pair is linked to the chemiluminescent composition by a linking group wherein the linking group comprises a hydrophilic macromolecule.

4. The method of claim 1 wherein a binding partner for the analyte is associated with the sensitizer reagent and the sensitizer reagent comprises a particle.

Assignees

• Singh Pratap
• Zheng Yi Feng
• Geng Liping
• Janzen Roland
• Schelp Carsten
• Siemens Healthcare Diagnostics

Inventors

• Singh Pratap
• Zheng Yi Feng
• Geng Liping
• Janzen Roland
• Schelp Carsten

Classifications

• G01N33/78 Primary

  Thyroid gland hormones {, e.g. T3, T4, TBH, TBG or their receptors} · CPC title

• G01N2333/59

  Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH] · CPC title

• G01N33/582 Primary

  with fluorescent label · CPC title